Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation

Abstract For most patients with acute myeloid leukemia (AML), an allogeneic hematopoietic stem cell transplantation (HSCT) offers the highest chance of cure. Recently, the European LeukemiaNet (ELN) published updated recommendations on the diagnosis and risk classification in AML based on genetic fa...

Full description

Bibliographic Details
Main Authors: Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer, Klaus H. Metzeler, Maximilian Merz, Vladan Vucinic, Georg-Nikolaus Franke, Marco Herling, Uwe Platzbecker, Sebastian Schwind
Format: Article
Language:English
Published: Nature Publishing Group 2022-12-01
Series:Blood Cancer Journal
Online Access:https://doi.org/10.1038/s41408-022-00764-9

Internet

https://doi.org/10.1038/s41408-022-00764-9

Similar Items